Website News and Research

RSS

Cognitive behavioral therapy more effective than antidepressant medications for bulimia nervosa

A new evidence report by ECRI Institute comparing the effectiveness of various treatments for bulimia nervosa indicates that cognitive behavioral therapy is more effective than antidepressant medications and supportive therapies in improving eating disorder symptoms.

2 Feb 2011

New national initiative to increase heart attack awareness among women

A woman suffers a heart attack every minute in the United States. But according to a 2009 American Heart Association survey, only half of women said they would call 9-1-1 if they thought they were having a heart attack -- and many women did not even recognize several key symptoms. This combination has led to dangerous consequences.

2 Feb 2011

Boston-based Research 2.0 begins Viral Genetics coverage, publishes initial report

Boston-based Research 2.0 initiated coverage of Viral Genetics, Inc, and published their initial report today. The report is available on the company's website at www.viralgenetics.com/investors/press-releases/R20Report and is also distributed over the internet and through institutional platforms including FactSet, CapitalIQ, and TheMarkets.com.

2 Feb 2011

New Spanish version of ASPIRE for Hispanic teens

The University of Texas MD Anderson Cancer Center's popular web-based teen prevention and smoking-cessation program, ASPIRE, now speaks Spanish.

2 Feb 2011

Seattle Genetics to sell common stock in underwritten public offering

Seattle Genetics, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares in the offering are to be sold by Seattle Genetics.

1 Feb 2011

Fox Chase announces posting of clinical outcomes data to its website for patient use

Fox Chase Cancer Center, one of the nation's leading cancer research and treatment institutions, today announced the posting of clinical outcomes data to its website as a tool to assist newly-diagnosed patients in deciding where to seek cancer care.

1 Feb 2011

Cal/OSHA reminds employers to post work-related injuries, illnesses that occurred during 2010

The Department of Industrial Relations' Division of Occupational Safety and Health, better known as Cal/OSHA, reminds all California employers to post at their place of business a summary of work-related injuries and illnesses that occurred during 2010.

1 Feb 2011

FDA schedules panel meeting date for BioMimetic Therapeutics's Augment Bone Graft PMA

BioMimetic Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled an Orthopedic and Rehabilitation Devices Panel meeting on May 12, 2011 to review the Company's Premarket Approval (PMA) application for Augment™ Bone Graft for the treatment of foot and ankle fusions in the U.S.

1 Feb 2011

Encision reports gross profit margin increase in third quarter of fiscal year 2011

Encision, a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported profitable financial results for its third fiscal quarter ended December 31, 2010.

31 Jan 2011

Athersys enters definitive agreements to sell common stock, warrants

Athersys, announced today that it has entered into definitive agreements with certain investors to sell 4,366,667 shares of its common stock and warrants to purchase up to an additional 1,310,000 shares of common stock in a registered direct offering for gross proceeds of approximately $13.1 million, before deducting fees and offering expenses.

29 Jan 2011

New research shows employer-sponsored plans to decline more slowly than commonly thought

Contrary to fears that recent health care legislation will trigger a rapid decline in employer-sponsored health coverage in the U.S., management consulting firm Booz & Company today published new research that shows employer-sponsored plans will decline more slowly and less steeply than commonly thought.

28 Jan 2011

Inovio to use proceeds from $24.3M offering for development of DNA vaccine against cervical dysplasias

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the closing of the sale to a single institutional investor of 21,130,400 shares of its common stock and warrants to purchase up to 10,565,200 additional shares of its common stock.

28 Jan 2011

Reduction in secondhand smoking associated with fewer cases of middle ear infection among children

Harvard School of Public Health (HSPH) researchers and colleagues from Research Institute for a Tobacco Free Society have found that a reduction in secondhand smoking in American homes was associated with fewer cases of otitis media, the scientific name for middle ear infection. The study appears on January 26, 2011, as an online first article on the website of the journal Tobacco Control.

28 Jan 2011

XYTOS shares cancer patient treatment results

XYTOS Shares Patient Results.

28 Jan 2011

Viewpoints: Is Obama abandoning his health victory?

Did Obama say enough about health care reform last night? I suppose I'm one of the very few people who would even ask that question. Most Americans would probably think, "More health care? Lord no." And I think Obama and his speechwriters sensed as much. Although his defense of the Affordable Care Act was clear -- he's not going to sign a bill repealing the law -- it was also short. That portion of the speech was just two brief paragraphs, by my count (Jonathan Cohn, 1/26).

28 Jan 2011

Positive results from RXi's sd-rxRNA technology for development of novel therapeutics

RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutics, announced today that, as part of its collaboration with miRagen Therapeutics, positive data were generated demonstrating that RXi's sd-rxRNA technology can be used, in vitro, to specifically enhance the activity of a microRNA of high interest to miRagen.

28 Jan 2011

Pfizer announces termination of HSR waiting period for acquisition of King

Pfizer Inc. today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) has been terminated in connection with the tender offer by its wholly-owned subsidiary, Parker Tennessee Corp., to purchase all outstanding shares of common stock of King Pharmaceuticals, Inc. for $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.

27 Jan 2011

PSS World Medical third quarter consolidated earnings per diluted share increase 16.6% to $0.35

PSS World Medical, Inc. announced today its results for the fiscal 2011 third quarter ended December 31, 2010.

27 Jan 2011

First Edition: January 27, 2011

In today's headlines, a range of health policy news -- including House hearings advanced by the GOP to further their repeal efforts and more reports about the budget deficit.

27 Jan 2011

Biotage announces release of new Analytical Sample Preparation Catalog

Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced the release of its new Analytical Sample Preparation Catalog. The expanded, 200-page catalog includes a range of products for Bioanalytical, Forensic, Clinical, Environmental, Agrochemical and Food Applications.

27 Jan 2011

Website News and Research

Cognitive behavioral therapy more effective than antidepressant medications for bulimia nervosa

New national initiative to increase heart attack awareness among women

Boston-based Research 2.0 begins Viral Genetics coverage, publishes initial report

New Spanish version of ASPIRE for Hispanic teens

Seattle Genetics to sell common stock in underwritten public offering

Fox Chase announces posting of clinical outcomes data to its website for patient use

Cal/OSHA reminds employers to post work-related injuries, illnesses that occurred during 2010

FDA schedules panel meeting date for BioMimetic Therapeutics's Augment Bone Graft PMA

Encision reports gross profit margin increase in third quarter of fiscal year 2011

Athersys enters definitive agreements to sell common stock, warrants

New research shows employer-sponsored plans to decline more slowly than commonly thought

Inovio to use proceeds from $24.3M offering for development of DNA vaccine against cervical dysplasias

Reduction in secondhand smoking associated with fewer cases of middle ear infection among children

XYTOS shares cancer patient treatment results

Viewpoints: Is Obama abandoning his health victory?

Positive results from RXi's sd-rxRNA technology for development of novel therapeutics

Pfizer announces termination of HSR waiting period for acquisition of King

PSS World Medical third quarter consolidated earnings per diluted share increase 16.6% to $0.35

First Edition: January 27, 2011

Biotage announces release of new Analytical Sample Preparation Catalog

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News